References
- OermannCMEnterovirusd68. A focused review and clinical highlights from the 2014 U.S. OutbreakAnn. Am. Thorac. Soc.201512 775 78110.1513/AnnalsATS.201412-592FR
- StanwayGStructure, function and evolution of picornavirusesJ. Gen. Virol.199071Part 112483250110.1099/0022-1317-71-11-2483
- LiuYShengJFokineAStructure and inhibition of EV-D68, a virus that causes respiratory illness in childrenScience2015347717410.1126/science.12619624307789
- WeiWGuoHChangJICAM-5/telencephalin is a functional entry receptor for enterovirus D68Cell Host Microbe20162063164110.1016/j.chom.2016.09.013
- LiuYShengJBaggenJSialic acid-dependent cell entry of human enterovirus D68Nat. Commun.2015610.1038/ncomms98654660200
- BaggenJThibautHJStaringJEnterovirus D68 receptor requirements unveiled by haploid geneticsProc. Natl. Acad. Sci. USA20161131399140410.1073/pnas.15244981134747778
- SchiebleJHFoxVLLennetteEHA probable new human picornavirus associated with respiratory diseasesAm. J. Epidemiol.19678529731010.1093/oxfordjournals.aje.a120693
- KhetsurianiNLamonte-FowlkesAOberstSPallanschMAEnterovirus surveillance—United States, 1970-2005MMWR Surveill. Summ.200655120
- Holm-HansenCCMidgleySEFischerTKGlobal emergence of enterovirus D68: a systematic reviewLancet Infect. Dis.201616e64e7510.1016/S1473-3099(15)00543-5
- TokarzRFirthCMadhiSAWorldwide emergence of multiple clades of enterovirus 68J. Gen. Virol.2012931952195810.1099/vir.0.043935-03542132
- SejvarJJLopezASCorteseMMAcute flaccid myelitis in the United States, August-December 2014: results of nationwide surveillanceClin. Infect. Dis.20166373774510.1093/cid/ciw3725709818
- MessacarKSchreinerTLMaloneyJAA cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USALancet20153851662167110.1016/S0140-6736(14)62457-0
- AliabadiNMessacarKPastulaDMEnterovirus D68 infection in children with acute flaccid myelitis, Colorado, USA, 2014Emerg. Infect. Dis.2016221387139410.3201/eid2208.1519494982171
- GreningerALNaccacheSNMessacarKA novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort studyLancet Infect. Dis.20151567168210.1016/S1473-3099(15)70093-9
- MessacarKRobinsonCCPrettyKYuanJDominguezSRSurveillance for enterovirus D68 in colorado children reveals continued circulationJ. Clin. Virol.201792394110.1016/j.jcv.2017.05.009
- StacpooleSRLMolyneuxABaumerDAcute segmental poliomyelitis-like flaccid paralysis in an adult in the UK, associated with enterovirus D68Pract. Neurol.20171729730110.1136/practneurol-2017-001609
- TanWWangYZhaoYLuRPrevalence and genetic characterization of enterovirus D68 among children with severe acute respiratory infection in ChinaJ. Clin. Virol.201682S113S11310.1016/j.jcv.2016.08.226
- RoldaoAMelladoMCCastilhoLRCarrondoMJAlvesPMVirus-like particles in vaccine developmentExpert Rev. Vaccin.201091149117610.1586/erv.10.115
- KushnirNStreatfieldSJYusibovVVirus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical developmentVaccine201231588310.1016/j.vaccine.2012.10.083
- LiuQYanKFengYA virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challengeVaccine2012306642664810.1016/j.vaccine.2012.08.071
- KuZLiuQYeXA virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in miceVaccine2014324296430310.1016/j.vaccine.2014.06.025
- ShenCKuZZhouYVirus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infectionsVaccine2016344025403110.1016/j.vaccine.2016.06.028
- ZhangCKuZLiuQHigh-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in miceVaccine2015332335234110.1016/j.vaccine.2015.03.034
- ZhangCLiuQKuZCoxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in miceAntivir. Res.2016129475110.1016/j.antiviral.2016.02.011
- ZhouYShenCZhangCYeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in miceAntivir. Res.201613216516910.1016/j.antiviral.2016.06.004
- KuZShiJLiuQHuangZDevelopment of murine monoclonal antibodies with potent neutralization effects on enterovirus 71J. Virol. Methods201218619319710.1016/j.jviromet.2012.06.025
- CaiYLiuQHuangXActive immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infectionVaccine2013312215222110.1016/j.vaccine.2013.03.007
- ReedLJMuenchHA simple method of estimating fifty per cent endpointsAm. J. Epidemiol.19382749349710.1093/oxfordjournals.aje.a118408
- LiuQDetection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteinsJ. Virol. Methods201117311512010.1016/j.jviromet.2011.01.016
- KuZYeXHuangXNeutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment stepsPLoS One20138e5760110.1371/journal.pone.00576013579802
- FengQHeYLuJVirus-like particles produced in Pichia pastoris induce protective immune responses against Coxsackievirus A16 in miceMed. Sci. Monit.2016223370338210.12659/MSM.9003805036384
- LiHYHanJFQinCFChenRVirus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in miceVaccine2013313281328710.1016/j.vaccine.2013.05.019
- ZhaoHLiHYHanJFVirus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in miceAppl. Microbiol. Biotechnol.201397104451045210.1007/s00253-013-5257-3
- FooDGIdentification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptidesVirus Res.2007125616810.1016/j.virusres.2006.12.005
- LiuCCChouAHLienSPIdentification and characterization of a cross-neutralization epitope of Enterovirus 71Vaccine2011294362437210.1016/j.vaccine.2011.04.010
- JiangLFanRSunSA new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in miceVaccine2015336596660310.1016/j.vaccine.2015.10.104
- ShiJHuangXLiuQHuangZIdentification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16Vaccine2013312130213610.1016/j.vaccine.2013.02.051
- FioreLRidolfiBGenoveseDPoliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodiesJ. Virol.19977169056912191973
- ChungYCHoMSWuJCImmunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challengeVaccine2008261855186210.1016/j.vaccine.2008.01.058